Top entities: Axsome Therapeutics, Nasdaq, United States, United States — Food and Drug Administration.

What category does this event fall under?

Business — classified as earnings announcement.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jul 14, 2026. Coverage continues to evolve.

Business earnings announcement

Axsome Q2 2026 earnings date set

Q: When did this event occur?

First reported Jul 14, 2026; last updated Jul 14, 2026.

Q: What is the market impact?

General. The announcement is a routine earnings date disclosure with minimal direct market impact.

Analysis based on 7 articles · First reported Jul 14, 2026 · Last updated Jul 14, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The announcement is a routine earnings date disclosure with minimal direct market impact. Investors may watch for updates on product sales and pipeline progress during the call.

biotechnology pharmaceuticals

Event Summary

Axsome Therapeutics announced it will report its second quarter 2026 financial results on August 10, 2026, before market open, followed by a conference call. The company is a biopharmaceutical firm focused on CNS disorders with FDA-approved products for depression, Alzheimer's agitation, narcolepsy/OSA, and migraine.

Key Actions

10 Axsome Therapeutics announced earnings date

Entities Involved

stock

Axsome Therapeutics

Axsome is the subject of the announcement; it will report Q2 2026 results and provide a business update.

Importance 100.0 Sentiment 0.0

exch

Nasdaq

Axsome is listed on Nasdaq under ticker AXSM; the exchange is mentioned as the listing venue.

Importance 10.0 Sentiment 0.0

cnt

United States

Axsome operates primarily in the United States, where its products are approved and marketed.

Importance 5.0 Sentiment 0.0

govactor

United States — Food and Drug Administration

The FDA has approved Axsome's products; the company references FDA in forward-looking statements regarding potential approvals.

Importance 5.0 Sentiment 0.0

Relationships

Nasdaq related ↔ United States

United States related ↔ United States — Food and Drug Administration

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard